LGALS3 and melanoma: Preliminary data of in vivo imaging of galectin-3 positive melanomas, lymphomas and breast carcinomas have been also obtained opening interesting possibilities for the future to use radio labeled mAbs to galectin-3 for in vivo imaging and treatment of different types of human malignancies [27]–[31].